Industry SupportESO is an independent organisation. It recognises that the industrial partners are crucial for the delivery of best cancer care and fosters the continuation of the dialogue and identification of synergies. It will restrain, however, the influence of marketing and strive to maintain its independence from the sponsors with whom it will interact with a neutral approach.
Industrial sponsorship is acknowledged from those companies who were willing to be Sustaining Members of the Learning to Care programme (from July 2004 renamed Sharing Progress in Cancer Care), which made possible the start of the Masterclass series, the launch of the scientific magazine CancerWorld and a number of educational events with no registration fee in underdeveloped areas of the world. Their financial donations to the School guarantee ESO’s scientific independence.
The companies who sustained the Learning to Care programme are Amgen, Astrazeneca, Aventis, Bristol Myers Squibb, Eli Lilly, Novartis, Ortho Biotech, Pharmacia Oncology and Roche.
The companies sustaining the Sharing Progress in Cancer Care programme are Amgen, Celgene Corporation, Eisai, Genomic Health, GlaxoSmithKline, Lilly, Merck Serono, Novartis, Roche and Sanofi Oncology.
Sharing Progress in Cancer Care
Programme Coordinator
Matti Aapro, Geneva
For further information please contact: dmengato@eso.net
|
